Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.705 USD | -3.64% | -3.28% | +23.08% |
Mar. 14 | Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
125M | - | - | - | |||
109B | ||||||
105B | ||||||
22.25B | - | |||||
22.09B | - | |||||
18.68B |
- Stock Market
- Equities
- VXRT Stock
- Charts Vaxart, Inc.
- Sector Chart